These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21429362)

  • 1. [B-cell lymphoma with concurrent myc/IgH and bcl-2/IgH translocations: report of a case].
    Li L; Liu YH; Zhuang HG; Luo DL; Xu FP; Luo XL; Xu J; Zhang KP
    Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):50-1. PubMed ID: 21429362
    [No Abstract]   [Full Text] [Related]  

  • 2. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
    Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-hit diffuse large B-cell lymphoma.
    Friedberg JW
    J Clin Oncol; 2012 Oct; 30(28):3439-43. PubMed ID: 22949152
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular Risk Stratification in Aggressive B-Cell Lymphomas.
    Frosch ZAK; Landsburg DJ
    J Clin Oncol; 2020 Jun; 38(18):2014-2017. PubMed ID: 32243222
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance and application of c-myc in diffuse large B-cell lymphoma].
    Huang WT; Lü N; Guo L
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):638-40. PubMed ID: 24314257
    [No Abstract]   [Full Text] [Related]  

  • 6. Double hit lymphoma: the MD Anderson Cancer Center clinical experience.
    Oki Y; Noorani M; Lin P; Davis RE; Neelapu SS; Ma L; Ahmed M; Rodriguez MA; Hagemeister FB; Fowler N; Wang M; Fanale MA; Nastoupil L; Samaniego F; Lee HJ; Dabaja BS; Pinnix CC; Medeiros LJ; Nieto Y; Khouri I; Kwak LW; Turturro F; Romaguera JE; Fayad LE; Westin JR
    Br J Haematol; 2014 Sep; 166(6):891-901. PubMed ID: 24943107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy.
    Takács I; Eros N; Bene I; Bozsó F; Tordai L; Károlyi Z; Radványi G; Matolcsy A
    Ann Hematol; 2004 Sep; 83(9):608-10. PubMed ID: 15205915
    [No Abstract]   [Full Text] [Related]  

  • 8. [Spindle cell variants of diffuse large B cell lymphoma: report of 2 cases].
    Wang JC; Shi DR; Fu XL; Lu CL; Lu WP
    Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):55-6. PubMed ID: 15796885
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanism and clinical significance of anti-apoptotic gene bcl-2 expression in diffuse large B-cell lymphoma].
    Zeng LP; Wen YL; Ma Y; Wang GQ; Li Y; Wang J; Xu LL; Zhang XM
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):377-81. PubMed ID: 21914345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHOP plus rituximab--balancing facts and opinion.
    Cheson BD
    N Engl J Med; 2002 Jan; 346(4):280-2. PubMed ID: 11807154
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary high-grade B-cell lymphoma of the breast with concurrent IGH-BCL2 and MYC-IGL translocations in an adolescent patient.
    Liang X; Jones A; Giller RH; Swisshelm K; McGavran L; Meltesen L; Carstens B; McGranahan AN; Albano EA
    Pediatr Dev Pathol; 2011; 14(5):402-6. PubMed ID: 21491965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How to improve the efficacy of R-CHOP for indolent B-cell lymphoma?].
    Tobinai K
    Rinsho Ketsueki; 2012 Jun; 53(6):609-17. PubMed ID: 22790636
    [No Abstract]   [Full Text] [Related]  

  • 13. Progressive sclerodermoid skin changes--quiz case.
    Dacso MM; Petitt MS; Berlingeri-Ramos AC; Kelly BC
    Arch Dermatol; 2012 Feb; 148(2):247-52. PubMed ID: 22351831
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppression due to MACOP-B does not seem to cure the antiphospholipid syndrome.
    Stefani PM; Pietrogrande F; Sartori R; Girolami A
    Haematologica; 1999 Aug; 84(8):751-2. PubMed ID: 10457414
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
    Green TM; Young KH; Visco C; Xu-Monette ZY; Orazi A; Go RS; Nielsen O; Gadeberg OV; Mourits-Andersen T; Frederiksen M; Pedersen LM; Møller MB
    J Clin Oncol; 2012 Oct; 30(28):3460-7. PubMed ID: 22665537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathological and molecular genetic characteristics of childhood diffuse large B cell lymphoma].
    Huang H; Yang WP; Xu HY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):209-11. PubMed ID: 22780976
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravascular large B-cell lymphoma associated with t(14;19)(q32;q13) translocation.
    Kobayashi T; Ohno H
    Intern Med; 2011; 50(18):2007-10. PubMed ID: 21921386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
    Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
    Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New concepts in treatment approaches and prognostic factors in aggressive NHL.
    Shipp M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):107-9. PubMed ID: 16728917
    [No Abstract]   [Full Text] [Related]  

  • 20. Unusual chest lesion: giant primary pulmonary lymphoma.
    Dobrilovic N; Wright CB; Vester SR; Patel MA; Fannin EA
    Ann Thorac Surg; 2005 Sep; 80(3):1134. PubMed ID: 16122515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.